Entities

Partner at Earlybird Venture Capital

General Partner at Earlybird Venture Capital

Partner Health Fund II at Earlybird Venture Capital

Partner at Earlybird Venture Capital

General Partner at Earlybird Venture Capital

Earlybird UNI-X Partner at Earlybird Venture Capital

Co-Founder and Partner at Earlybird Venture Capital

Partner at Decibel Partners

Partner at Decibel Partners

Founding Partner at Decibel Partners

Partner at Earlybird Venture Capital

Partner at Earlybird Venture Capital

General Partner at DCVC

Partner at DCVC (Data Collective)

General Partner at DCVC

Partner and COO at DCVC

General Partner at DCVC

John Hamer serves as Board Observer at Newleos Therapeutics, a clinical-stage neuroscience company.

Chief Product Officer and business development leader at Volumez, which develops enterprise AI data infrastructure and cloud storage software.

Zachary Bogue is Managing Partner at DCVC and is listed in Relation’s current board and observers directory. Relation does not separately label his exact board-versus-observer capacity.

Partner at DCVC | Deep Tech Investor

General Partner at DCVC

Partner at DCVC

Founder and General Partner at Day One Ventures

Scott Barclay serves on Cleerly’s board. Its current biography identifies him as an Insight Partners managing director focused on healthcare technology since 2021. Insight Partners source, reviewed October 8, 2026: I joined Insight Partners as a Managing Director in 2021 to bring to life our vision to be the best healthtech venture capital firm in the world. How we as humans provide healthcare reflects both the best in humanity—healthcare heroes, loving care and astounding innovation—but it also reflects our shortcomings. Our healthcare system is oligopolistic and sclerotic, prone to regulatory capture, political division and poor experiences, and creates inequities of access and quality that reflect our historical failures. And yet, healthcare is critical and deeply personal for all of us. It’s also a huge and growing portion of our economy. It’s both a societal foundation and the predominant driver of personal bankruptcy. While there are many ways to try to fix our broken healthcare system, I focus on just one: how teams—armed with technical prowess and an earned empathy to the problem—can build something greater than themselves in healthcare with software and data. In fact, everything in my past contributes to this one focus—from capital markets to INSEAD to BCG, then operating businesses at CVS Health, to fixing and scaling e-prescriptions at Surescripts. And now, for the past 10 years, I’ve been an investor who walks closely with founders—as an angel investor, a partner at DCVC, and now here at Insight. I love serving at Insight for three reasons. First, the firm has a positive, high trust, “do the work” culture from the bottom-up. Second, we have amazing resources and experience to support our CEOs and help them scale their companies at every stage. And third, we have an ability to invest at any stage, which discourages FOMO and enables true long-term “first principles” investing. For me personally, what I love most is a great team process that leads to discovering and serving the best founders. Once on the cap table, I focus my time with founders on building trust, building teams, and identifying the few things that truly matter. I live and work in Palo Alto, CA. To my friends, I hope to be known as someone who is always learning, always listening, usually walking and always grateful.

Principal at Day One Ventures

Co-Managing Partner at DCVC (Data Collective)

Founding Partner at Data Collective

Equity Partner at DCVC

Board Partner at Credo Ventures

CFO at Credo Ventures

General Partner at Credo Ventures

Venture Partner at Crane Venture Partners

Co-founder and Partner at Crane Venture Partners

Founder and General Partner at Cortical Ventures

General Partner at Cortical Ventures

Co-founder at Contrarian Ventures

Principal at Contrarian Ventures

Partner at Contrarian Ventures

Founder & Managing Partner at Contrarian Ventures

General Partner at Contrarian Ventures

VP Portfolio Talent at Cherry Ventures

Investor at Cherry Ventures

Earlier record: Principal at Cherry Ventures. Charlotte Bruce is published by Techstars as General Manager EMEA & APAC. The current published directory verifies the named affiliation; exact appointment dates are undisclosed.

Founder & Managing Partner at Chemistry

Partner at Cherry Ventures Jasper Masemann is General Partner at Discovery Ventures. The current firm directory states: Jasper Masemann General Partner Partner - Cherry & HV Capital Solo Founder - greatcontent.

Managing Partner, Co-Founder @ Chemistry

Venture Partner at Cherry Ventures

Principal at Cherry Ventures

Founding Partner at Cherry Ventures

Partner at Cherry Ventures

Founding Partner at Cherry Ventures

VC at Cherry Ventures

Investor at Cherry Ventures

Investor at Cherry Ventures

Partner at Cherry Ventures

Zach Perret is co-founder and CEO of Plaid, a financial data and infrastructure company he founded with William Hockey in 2013. Plaid’s own May 2026 product announcement identifies his current CEO role and work on financial analytics and foundation models for fraud, credit, payments and financial management. Duke’s entrepreneurship network identifies him as Zachary Perret, a 2010 graduate. Comulate’s February 2025 issuer announcement identifies Plaid’s Zach Perret personally as an earlier investor; the source does not establish his financing stage, cash ticket, investment date, board role or participation in the new Series B.

Sofia Garcia is Cantos’s chief financial officer, leading finance and operations in SanFrancisco. The firm’s own current biography lists prior back-office leadership at SlowVentures, BracketCapital and JLLSpark, following three years as a programme manager at JPMorgan and a year at UBS. Her exact existing Cantos role independently anchors identity and distinguishes unrelated people with the same name.

Investor at Cantos Ventures

Amee Kapadia is a principal at Cantos in SanFrancisco. She joined in2021 and leads investments across AI, biotechnology and robotics. The firm’s own biography identifies her as co-founder of DecodingBio and the AIxBioSummit and a board observer at MoldCo. She holds an MS in BiomedicalEngineering from JohnsHopkins and an MBA from Stanford. These current manager affiliations do not imply individual personal investments.

Managing Partner at Celesta Capital

Partner at Celesta Capital

Cofounder and Managing Director at Catapult Ventures

Ian Rountree founded Cantos in2016 to invest in innovation beyond conventional SiliconValley software markets. The firm’s own current biography identifies prior early-team roles at Invisible Technologies and SoFi and his focus on technically ambitious founders building technology in the physical world. His founder-authored fund announcements describe the firm’s evolution from initial angel investing into near-frontier venture funds. Regulatory documents separately name Julian H. Rountree as the adviser’s managing member; no separate Julian person is created without a proven alias bridge. Retained earlier profile text (source-qualified historical where superseded): General Partner at Cantos

Founding Managing Partner at Celesta Capital He is also the manager of A&E Investment LLC, a family-trust-owned entity identified in a primary SEC filing; its investments are distinct from his personal holdings. Intel’s current biography identifies him as chief executive officer and board member, appointed in March2025, and as a founding managing partner of Walden Catalyst Ventures and chairman of Walden International. He previously led Cadence Design Systems for12years. He holds physics, nuclear engineering and business degrees from Nanyang Technological University, MIT and the University of San Francisco, respectively.

Founder and Managing Partner at Celesta Capital

Partner at Celesta Capital

Co-Founder and Managing Director at Catapult Ventures

Partner at Celesta Capital

Partner at Celesta Capital

Founding Partner at Breega

Senior Associate at Breega

Partner at Breega

Co-Founder and General Partner/COO at Breega at Breega

Partner at Breega

Portfolio Manager - Middle Office Assistant at Breega

Senior Associate at Breega

Investor at Breega

Member of the Investment Committee & VC Investor at Breega Capital

Partner at Breega

Partner at Breega

Venture Partner at Breega

Senior Associate at Breega

Investor at BoxGroup

Partner at BoxGroup

Partner at BoxGroup

Partner at BoxGroup

Managing Partner at BoxGroup

Investor at BoxGroup

Investor at BoxGroup

Director, Head of Corporate Development at Box

Partner at BoxGroup

Investment Principal at Robert Bosch Venture Capital

Investment Partner at Robert Bosch Venture Capital

Founder and Managing Partner at BOLDstart Ventures

General Partner at Boldstart Ventures

Principal at BNVT Capital

Limited Partner at Boldstart Ventures

Investor at Bodhi Ventures

Partner at Boldstart ventures

Senior Associate at Boldstart Ventures

Investor at Boldstart Ventures

Ray Johnson is a published member of Zeno Power’s advisory board. The company directory describes this background: Former Chief Technology Officer, Lockheed Martin Corporation. This directory background does not establish an additional current employer appointment.